Unified Agenda
This article was originally published in The Tan Sheet
Executive Summary
HHS issues its semi-annual regulatory agenda, published in the Federal Register April 30. Among many 1planned FDA actions is a proposed rule on qualified health claims, with its publication date to be determined. FDA also slates a number of actions for 2007 on OTC monographs, including proposed and final actions within the cough/cold and internal analgesics monographs. The agency set a December 2007 deadline for completion of dietary supplement GMPs, which have now been reviewed by the Office of Management and Budget...
You may also be interested in...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.